Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 03 May 2023
Even though Wilms tumor, also known as nephroblastoma, is uncommon, it is the most common form of pediatric kidney cancer. Children's Hospital Los Angeles researchers have now identified a disruption in early kidney progenitor cells.
Read Full News‘A strength of the nurse practitioner profession is its versatility,’ one expert says.
Emotionally drained, sleep-deprived, and skipping meals to keep up: what nurse leaders say needs to change to prevent burnout.
Most family physicians face heavy administrative burden, but improved electronic health records and staff support may help to ease some of the load.
Bloating is one of patients' most common gastrointestinal complaints. Dr Alicia Muratore kicks off this six-part series by asking why bloating is often treated as an afterthought.
Drs Anne Lenore Ackerman and Rachel S. Rubin discuss urinary tract infections, sexual function, quality of life, and the importance of patient education.
Prof David Kerr explores whether PD-1 inhibitors and targeted vaccines can regress polyps and prevent secondary cancers in Lynch syndrome.
State telehealth coverage parity laws require private insurers to cover outpatient telehealth visits increasing access for HF patients. This analysis examines whether this affected clinical outcomes.
1.
Relationship-building key to addressing oncologist shortages in rural care
2.
New protein target discovered for childhood medulloblastomas
3.
Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL
4.
Papillary thyroid cancer: New markers offer hope for tailored treatment
5.
Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal
1.
Precision Oncology: Tailoring Cancer Treatment for the Individual
2.
Genetic Screening: A Game Changer in Cancer Prevention
3.
A Visual Journey Through Penile Cancer: Examining the Impact of Photos
4.
The Architect's Dilemma: Remodeling the Tumor Microenvironment for a New Era of Cancer Immunotherapy
5.
From Bench to Bedside: The New Era of Lymphoma Treatment and Education
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
4.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge